Eagle Meds Services
Ibrance (palbociclib)
Available to sourceHuman Prescription DrugOncology & Specialty

Ibrance (palbociclib)

125 mg/1 · Capsule
By Pfizer Laboratories Div Pfizer Inc
NDC
0069-0189
Route
Oral
Therapeutic class
Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor , Kinase Inhibitors [MoA]
Marketing category
NDA

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request this medication

Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

Requesting
Ibrance (palbociclib)
NDC 0069-0189